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Items for this week’s Epi Update include: 
• High RSV activity in Iowa 
• Reminder: Neisseria meningitidis prevention 
• Three congenital syphilis cases reported in Iowa in 2018 
• In the news: Clinical trial testing fecal microbiota transplant for recurrent 
diarrheal disease begins 
• In the news: Ten threats to global health in 2019 
• In the news: When a trip to the doctor leads to a chat about antibiotics 
• Infographic: Protect your child from RSV 
• Meeting announcements and training opportunities 
 
High RSV activity in Iowa 
The annual respiratory syncytial virus (RSV) season occurs fall through spring in most regions 
of the U.S. and Iowa has seen a recent increase in RSV activity throughout the state. Over the 
past four weeks, 872 positive RSV results were reported among 4,702 specimens (18.5 
percent) at Iowa laboratories participating in SHL surveillance. 
 
RSV is a common virus that usually causes mild, cold-like symptoms from which most people 
recover in under two weeks. However, RSV can cause severe illness, especially in premature 
infants, those under 6 months or over 65 years, and those with chronic respiratory, heart and 
immune system conditions. Each year in the U.S., an estimated 57,000 children under 5 and 
177,000 older adults are hospitalized due to RSV and 14,000 older adults die. 
 
Contact and standard precautions should be used when working with patients confirmed or 
suspected to be infected with RSV for the duration of their illness. Per standard precaution 
guidelines, eye, nose and mouth protection for health care providers is recommended when it 
is likely there will be spray of respiratory secretions from a patient. Patients who are coughing 
should also be asked to wear a mask.  
 
There is no RSV vaccine, but health care providers can give palivizumab to help protect some 
babies at high risk for severe disease. Many of the actions to prevent RSV are the same as 
with influenza and other respiratory infections: hand hygiene, staying home when ill, avoiding 
contact with sick people, respiratory hygiene and regular cleaning of frequently used surfaces. 
 
For more information about RSV, visit www.cdc.gov/rsv/index.html.  
 
For more information about infection control and RSV, visit 
www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines-H.pdf.  
 
Reminder: Neisseria meningitidis prevention 
Illness due to N. meningitidis can be a serious, life-threatening situation that requires prompt 
recognition and intervention. Humans are the only known reservoir for this bacteria, and up to 
10 percent of adolescents and adults may be transient carriers. As with many conditions, 
prevention is an important part of protecting the public’s health. Meningococcal conjugate 
vaccine (A,C,W,Y) is now required for students entering seventh and 12th grade at public and 
private schools in Iowa. 
 
When a case of N. meningitidis is identified, it is important to quickly identify contacts that 
might need antimicrobial chemoprophylaxis. Antimicrobial chemoprophylaxis is aimed at 
persons who are at a higher risk of becoming a secondary case because they were in close 
contact with a patient who had evidence of invasive disease. In this situation, the bacteria has 
proven it can cause significant illness and therefore, the goal is to provide protection to 
contacts within 24 hours of identifying the case. Close contacts that may be at increased risk 
include household members, child care contacts and anyone who is directly exposed to a 
patient’s oral secretions. Antimicrobial chemoprophylaxis should also be considered for 
persons who traveled in a plane or vehicle directly next to a patient for more than 8 hours. 
Recommended choices for chemoprophylaxis include rifampin, ciprofloxacin or ceftriaxone. 
 
Importantly, antimicrobial chemoprophylaxis is NOT recommended for close contacts of a 
patient who had N. meningitidis only in a non-sterile location (e.g., oropharyngeal, 
endotracheal or conjunctival). This is because some people may carry this organism and 
reports of secondary cases after close contact to persons with noninvasive infections are rare. 
Further, asymptomatic nasopharyngeal carriers do not require treatment. 
 
For more information about N. meningitidis, visit 
www.cdc.gov/vaccines/pubs/pinkbook/mening.html. 
 
Three congenital syphilis cases reported in Iowa in 2018 
2018 marked a record breaking year for congenital syphilis in Iowa. Three cases met the case 
definition for congenital syphilis in 2018: two in central Iowa and one in western Iowa. This 
continues an upward trend over the last several years in Iowa. In 2014 there was one case of 
congenital syphilis reported, another in 2016 and two in 2017. From 2008 - 2013 there were no 
cases reported.  
 
Although the majority of syphilis cases among adults occur in men, there has been an upward 
trend for syphilis in women that has corresponded to the increase in congenital syphilis cases 
reported in Iowa and across the U.S. 
 
Congenital syphilis occurs when a pregnant woman is infected with syphilis and does not 
receive adequate treatment, thus passing the infection on to the fetus or newborn. Congenital 
syphilis can lead to very serious health consequences, including stillbirth or neonatal death. 
Early diagnosis and treatment of syphilis among pregnant women is key in preventing 
congenital syphilis. CDC recommends that all pregnant women be tested for syphilis at their 
first prenatal appointment. It is not uncommon for women to become infected during 
pregnancy, therefore repeat syphilis testing is often beneficial early in the third trimester (28 
weeks) and at delivery. 
 










In the news: Ten threats to global health in 2019 
www.who.int/emergencies/ten-threats-to-global-health-in-2019  
 




Infographic: Protect your child from RSV 
 
 
To view in full size, visit www.cdc.gov/rsv/infographic.html.  
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
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